BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2020 8:24:58 AM | Browse: 847 | Download: 1133
 |
Received |
|
2020-02-26 11:56 |
|
Peer-Review Started |
|
2020-02-26 11:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-26 21:15 |
|
Revised |
|
2020-05-09 14:22 |
|
Second Decision |
|
2020-05-27 09:47 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-05-28 21:45 |
|
Articles in Press |
|
2020-05-28 21:45 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-06-05 05:49 |
|
Typeset the Manuscript |
|
2020-07-24 08:41 |
|
Publish the Manuscript Online |
|
2020-07-26 08:24 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Review |
| Article Title |
Potential of transposon-mediated cellular reprogramming towards cell-based therapies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dharmendra Kumar, Taruna Anand, Thirumala R Talluri and Wilfried A Kues |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dharmendra Kumar, PhD, Senior Scientist, Animal Physiology and Reproduction Division, ICAR-Central Institute for Research on Buffaloes, Grass Farm Road, Hisar 125001, India. dharmendra.kumar@icar.gov.in |
| Key Words |
Transposons; Induced pluripotent stem cells; Clinical applications; Cellular reprogramming; Cell-based therapy; Genetic correction |
| Core Tip |
Seminal discovery of induced pluripotent stem (iPS) cells have opened up the possibility of converting most somatic cell types into a pluripotent state. The iPS cells possess most of the advantages of embryonic stem cells without the ethical stigma associated with derivation of the latter. This procedure has had a large impact on generation of custom-made pluripotent cells, ideal for cell-type specific differentiation and regenerative medicine with or without genetic correction. In this review, we focus on updated information of transposon system-mediated cellular reprogramming to iPS cells and their application in cellular therapy. |
| Publish Date |
2020-07-26 08:24 |
| Citation |
Kumar D, Anand T, Talluri TR, Kues WA. Potential of transposon-mediated cellular reprogramming towards cell-based therapies. World J Stem Cells 2020; 12(7): 527-544 |
| URL |
https://www.wjgnet.com/1948-0210/full/v12/i7/527.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v12.i7.527 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
